Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation

American Journal of Gastroenterology

Volumn 95, Issue 9, 2000, Pages 2343-2351

  Trautwein, Christian ^a   Possienke, Martin ^b   Schlitt, Hans Jörg ^b   Böker, Klaus H W ^b   Horn, Roland ^b   Raab, Rudolph ^b   Manns, Michael P ^b   Brabant, Georg ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Medizinische Hochschule Hannover ^*

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; OSTEOCALCIN; PARATHYROID HORMONE; PROCOLLAGEN; TACROLIMUS; VITAMIN D;

ADULT; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE METABOLISM; CHOLESTATIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; OSTEOPOROSIS; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIRUS HEPATITIS;

ADULT; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CALCIUM; CHOLESTASIS; CHRONIC DISEASE; FEMALE; GRAFT REJECTION; HEPATITIS, VIRAL, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; PROGNOSIS; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TRANSAMINASES;

EID: 0033834502     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)01061-3     Document Type: Article

References (31)

1. Osteoporosis in chronic liver disease: Pathogenesis, risk factors, and management
2. Bone disease in liver transplant recipients
3. Management of osteopenia of liver disease with special emphasis in primary biliary cirrhosis
4. The clinical expression of primary biliary cirrhosis
5. Prevalence and prediction of osteopenia in chronic liver disease
6. The metabolic bone disease of primary sclerosing cholangitis
7. Primary biliary cirrhosis and bone disease
8. Factors influencing the development of metabolic bone disease in primary biliary cirrhosis
9. Low bone turnover state in primary biliary cirrhosis
10. Bone loss and reduced osteoblast function in primary biliary cirrhosis
11. Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis
12. Bone balance and turnover characteristics in osteopenia of primary biliary cirrhosis
13. Bone loss after orthotopic liver transplantation
14. Osteoporosis and bone mineral metabolism in cirrhotic patients referred for orthotopic liver transplantation
15. Precision of dual x-ray absorptiometry and peripheral computed tomography using mobile densitometry units
16. Forearm BMD as measured by peripheral quantitative computed tomography (pQCT) in a German reference population
17. Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2
18. Clinical relevance of mutations in the precore genome of the hepatitis B virus
19. Characterization of a new group of autoimmune chronic active hepatitis by antibodies directed against a soluble liver antigen
20. Endoscopic management of biliary tract strictures in primary sclerosing cholangitis
21. Interpretation of serum total calcium, effects of adjustment for albumin concentration on frequency of abnormal values and on detection of the change in the individual
22. Selective determination of c-terminal (70-84) hPTH, elevated concentrations in cholestatic liver disease
23. Bone loss after liver transplantation
24. Bone disease in liver transplant recipients: Incidence, timing, and risk factors
25. Circulating osteocalcin in primary biliary cirrhosis following liver transplantation during treatment with cyclosporin
26. Hyperbilirubinemia inhibits osteoblast proliferation: Role of Bilirubin in the development of cholestatic cirrhosis
27. Hepatic osteodystrophy in primary biliary cirrhosis, a possible defect in Kupffer cell cleavage of parathyreoid hormone
28. Carboxy-terminal parathyroid fragments stimulate osteoclast-like cell formation and osteoclastic activity
29. Evidence of estrogen receptors in normal human osteoblast-like cells
30. Etidronate versus fluoride for treatment in primary biliary cirrhosis: Preliminary results after 2 years